Literature DB >> 4630714

Provocation of schizophrenic symptoms by intravenous administration of methylphenidate.

D S Janowsky, M K el-Yousel, J M Davis, H J Sekerke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4630714     DOI: 10.1001/archpsyc.1973.01750320023004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  50 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Comparison of oral and intravenous methylphenidate.

Authors:  D S Janowsky; P Leichner; P Clopton; L L Judd; D Parker; L Huey
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

3.  Oxotremorine treatment restores hippocampal neurogenesis and ameliorates depression-like behaviour in chronically stressed rats.

Authors:  J Veena; B N Srikumar; K Mahati; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

4.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

5.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

6.  Correlations of normality and nervousness with cardiovascular functions in pointer dogs.

Authors:  J E Newton; J L Chapin; O D Murphree
Journal:  Pavlov J Biol Sci       Date:  1976 Apr-Jun

7.  Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia.

Authors:  J Gerlach; N Bjørndal; E Christensson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Amphetamine response and relapse risk after depot neuroleptic discontinuation.

Authors:  B Angrist; E Peselow; M Rubinstein; A Wolkin; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  The syndrome of Karl Ludwig Kahlbaum.

Authors:  M P Barnes; M Saunders; T J Walls; I Saunders; C A Kirk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

Review 10.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.